New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
14:03 EDTADXSAdvaxis treatment of osteosarcoma designated for orphan status
The company's live attenuated bioengineered Listeria monocytogenes immunotherapy was designated for orphan status as an osteosarcoma treatment, according to a post to the FDA's website. Reference Link
News For ADXS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
16:26 EDTADXSAdage Capital Partners reports 18.84% passive stake in Advaxis
Subscribe for More Information
December 15, 2014
07:33 EDTADXSAdvaxis announces FDA acceptance of INDA to commence clinical trials of ADXS-HPV
Subscribe for More Information
December 8, 2014
09:20 EDTADXSOn The Fly: Pre-market Movers
Subscribe for More Information
07:35 EDTADXSAdvaxis reports FDA acceptance of IND application for ADXS-PSA combination trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use